The US is the bigger Anti-Depressants Drugs market: $7.6 Bn against $328 Mn in 2023, about 23 times as large.
India grows faster: 5.7% a year, against 0.7%. The gap still grows from $7.2 Bn to $7.5 Bn by 2033.
Clinical research: 936 active trials in the US, 13 in India.
| Measure |  US |  India |
|---|---|---|
| Market size, 2023 | $7.6 Bn | $328 Mn |
| Market size, 2033 projected | $8.1 Bn | $570 Mn |
| Growth a year (CAGR) | 0.7% | 5.7% |
| Money added, 2023–2033 | $547 Mn | $243 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $22 | $0.22 |
| Active clinical trials | 936 | 13 |
| Full report | US report | India report |
Year by year, 2023 to 2033
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Anti-Depressants Drugs, US or India?
The US is the bigger Anti-Depressants Drugs market: $7.6 Bn against $328 Mn in 2023, about 23 times as large.
Which grows faster in Anti-Depressants Drugs, US or India?
India grows faster: 5.7% a year, against 0.7%. The gap still grows from $7.2 Bn to $7.5 Bn by 2033.
More Anti-Depressants Drugs comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.